|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Aug―12 |
Acquired idiopathic generalized anhidrosis (AIGA) associated with SARS-CoV-2 infection |
Hye Ryung Kwon, Dae Woong Bae, Jae Young An |
2 |
[GO] |
2024―Apr―15 |
A retrospective cohort study: is COVID-19 BNT162b2 mRNA vaccination a trigger factor for cluster headache? |
Suna Aşkın Turan, Şenay Aydın |
3 |
[GO] |
2024―Jan―13 |
Living with facioscapulohumeral muscular dystrophy during the first two COVID-19 outbreaks: a repeated patient survey in the Netherlands |
Johanna C. W. Deenen, Joost Kools, Anna Greco, Renée Thewissen, Wiecke van de Put, Anke Lanser, et al. (+4) Leo A. B. Joosten, Andre L. M. Verbeek, Baziel G. M. van Engelen, Nicol C. Voermans |
4 |
[GO] |
2023―Nov―14 |
Potential beneficial effect of IFN-β1a and ocrelizumab in people with MS during the COVID-19 pandemic |
Stefan Todorović, Slobodan Vojinović, Dejan Savić, Dejan Aleksić, Miloš Danilović |
5 |
[GO] |
2023―Sep―05 |
Spectrum of various CNS inflammatory demyelination diseases following COVID-19 vaccinations |
Manish Salunkhe, Kamlesh Tayade, Megha Priyadarshi, Vinay Goel, Isha Gulati, Ajay Garg, et al. (+2) Rohit Bhatia, M. V. Padma Srivastava |
6 |
[GO] |
2023―Jul―19 |
Miller Fischer syndrome after COVID-19 infection and vaccine: a systematic review |
Panayiota Neophytou, Artemios Artemiadis, Georgios M. Hadjigeorgiou, Panagiotis Zis |
7 |
[GO] |
2023―Jul―11 |
Correspondence on COVID-19 vaccination uptake in people with multiple sclerosis |
Amnuay Kleebayoon, Viroj Wiwanitkit |
8 |
[GO] |
2023―Jul―04 |
Secondary progressive COVID-19-associated extensive leukoencephalopathy |
Shugang Cao, Minqiang Bao, Rongfeng Wang, Mingwu Xia |
9 |
[GO] |
2023―Jun―01 |
COVID-19 vaccination uptake in people with multiple sclerosis compared to the general population |
Dijana Mayer, Barbara Barun, Karla Lazibat, Slava Lasić, Ivan Adamec, Tereza Gabelić, et al. (+2) Magdalena Krbot Skorić, Mario Habek |
10 |
[GO] |
2023―Mai―25 |
The functional and structural changes in the hippocampus of COVID-19 patients |
Ali Nouraeinejad |
11 |
[GO] |
2023―Mrz―20 |
Response to: Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination |
Sohyeon Kim, Minsung Kang, Jin-Sung Park, Hung Youl Seok |
12 |
[GO] |
2023―Mrz―03 |
Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination |
Amnuay Kleebayoon, Viroj Wiwanitkit |
13 |
[GO] |
2023―Feb―13 |
Risk and characteristics of Bell’s palsy in adults as an adverse event following COVID-19 vaccination: a retrospective study |
Sohyeon Kim, Minsung Kang, Jin-Sung Park, Hung Youl Seok |
14 |
[GO] |
2023―Jan―19 |
Female migraine patients had lower COVID-19 phobia and PCL-5 scores during the lockdown period |
Çile Aktan, Tuğçe Toptan, Çisem Utku, Hayrunnisa Bolay |
15 |
[GO] |
2023―Jan―12 |
Patient satisfaction with televisit in chronic neurologic disorders during Covid-19 pandemic |
Irene Rosellini, Marika Vianello, Anna Palmieri, Silvia Vittoria Guidoni, Federico Giopato, Anna Ghazaryan, et al. (+6) Matteo Fuccaro, Alberto Terrin, Roberta Vitaliani, Maria Teresa Rigoni, Francesco Pietrobon, Domenico Marco Bonifati |
16 |
[GO] |
2022―Dez―16 |
Do prior neurological comorbidities predict COVID-19 severity and death? A 25-month cross-sectional multicenter study on 7370 patients |
Mojtaba Sharafkhah, Farah Moayedi, Nozhan Alimi, Zeinab Haghighi Fini, Mohsen Ebrahimi-Monfared, Ali Massoudifar |
17 |
[GO] |
2022―Dez―14 |
Correction to: Clinical characteristics of 365 hospitalized COVID-19 patients with neurological symptoms: an observational study |
Fahimeh Vahabizad, Mansoureh Togha, Shadi Ariyanfar, Mohammad-Reza Fattahi, Samaneh Haghighi, Zahra Ebadi, et al. (+8) Sanaz Ahmadi Karvigh, Sara Heidari, Maryam Shafaei, Hale Ashraf, Azar Haddadi, Mohammad Talebpour, Arash Safaei, Hoda Asefi |
18 |
[GO] |
2022―Dez―07 |
Triggers and clinical changes of childhood primary headache characteristics during COVID-19 pandemic lockdown |
Özge Dedeoglu, Bahadır Konuşkan |
19 |
[GO] |
2022―Nov―22 |
Diagnostic challenges of functional neurological disorders after covid-19 disease or vaccination: case series and review of the literature |
Sergiu Albu, Margarita Vallès, Hatice Kumru |
20 |
[GO] |
2022―Nov―16 |
COVID-19 and Parkinson’s disease: a systematic review and meta-analysis |
Maryam Afraie, Ghobad Moradi, Pardis Mohammadzedeh, Mobin Azami, Sevda Riyahifar, Yousef Moradi |
21 |
[GO] |
2022―Nov―16 |
A review of the potential neurological adverse events of COVID-19 vaccines |
Zeinab Mohseni Afshar, Akanksha Sharma, Arefeh Babazadeh, Ali Alizadeh-Khatir, Terence T. Sio, Mohamad Ali Taghizadeh Moghadam, et al. (+5) Ali Tavakolli Pirzaman, Ahmadreza Mojadad, Rezvan Hosseinzadeh, Mohammad Barary, Soheil Ebrahimpour |
22 |
[GO] |
2022―Nov―04 |
Immune responses following COVID-19 infection in multiple sclerosis patients using immunomodulatory therapy |
Nuray Bilge, Fatma Kesmez Can, Recep Yevgi |
23 |
[GO] |
2022―Okt―24 |
COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis |
Stojan Peric, Milos Rankovic, Ivo Bozovic, Vanja Radosavljevic, Ivan Marjanovic, Ivana Basta, Dragana Lavrnic |
24 |
[GO] |
2022―Okt―22 |
Study of sympathetic skin response in patients with COVID-19 infection |
Sharareh Roshanzamir, Leila Sadat Mohamadi Jahromi |
25 |
[GO] |
2022―Okt―22 |
Comment on “Neuromuscular complications after COVID-19 vaccination: a series of eight patients” by Leemans et al. |
Giuliana Galassi, Alessandra Ariatti |
26 |
[GO] |
2022―Aug―25 |
Clinical characteristics of 365 hospitalized COVID-19 patients with neurological symptoms: an observational study |
Fahimeh Vahabizad, Mansoureh Togha, Shadi Arianfar, Mohammad-Reza Fattahi, Samaneh Haghighi, Zahra Ebadi, et al. (+8) Sanaz Ahmadi Karvigh, Sara Heidari, Maryam Shafaei, Hale Ashraf, Azar Haddadi, Mohammad Talebpour, Arash Safaei, Hoda Asefi |
27 |
[GO] |
2022―Aug―02 |
Epidemiology, clinical features, and treatment modalities of facial nerve palsy in COVID-19 patients: a systematic review |
Aya Turki, Kirellos Said Abbas, Abdelrahman M Makram, Mostafa Elfert, Mahmoud Elmarabea, Nahla Ahmed El-Shahat, et al. (+4) Hassan Abdalshafy, Akua Sampong, Sirisha Chintalapati, Nguyen Tien Huy |
28 |
[GO] |
2022―Jul―30 |
Seizures in COVID-19: the relationship between biomarkers and prognosis |
Pınar Bengi Boz, Kezban Aslan-Kara, Zeynep Selcan Şanlı, Mehmet Taylan Peköz, Dilek Acar, Hacer Bozdemir |
29 |
[GO] |
2022―Jul―14 |
Opsoclonus myoclonus ataxia syndrome following COVID-19 infection |
Ismail Ibrahim Ismail, Walaa A. Kamel, Ayman Kilany |
30 |
[GO] |
2022―Jul―07 |
A questionnaire-based survey of acceptability and satisfaction of virtual neurology clinic during COVID-19 lockdown: a preliminary study |
Anand Kumar, Neha Lall, Abhishek Pathak, Deepika Joshi, Vijaya Nath Mishra, Rameshwar Nath Chaurasia, Varun Kumar Singh |
31 |
[GO] |
2022―Jun―26 |
Evaluation of cognitive, mental, and sleep patterns of post-acute COVID-19 patients and their correlation with thorax CT |
Ömer Faruk Bolattürk, Akın Cem Soylu |
32 |
[GO] |
2022―Jun―25 |
Alexia without agraphia in an elderly man due to stroke secondary to COVID-19 infection |
Faheem Arshad, Vikram Singh, Chandrajit Prasad, Ravi Yadav, Suvarna Alladi |
33 |
[GO] |
2022―Jun―20 |
A case of transient POTS following COVID-19 vaccine |
Jeonghyun Park, Sanghyun Kim, Jusuck Lee, Jae Young An |
34 |
[GO] |
2022―Jun―12 |
Eotaxin-1 (CCL11) in neuroinflammatory disorders and possible role in COVID-19 neurologic complications |
Donya Nazarinia, Mahin Behzadifard, Javad Gholampour, Roqaye Karimi, Mohammadali Gholampour |
35 |
[GO] |
2022―Jun―07 |
The relevance of headache as an onset symptom in COVID-19: a network analysis of data from the LONG-COVID-EXP-CM multicentre study |
César Fernández-de-las-Peñas, Umut Varol, Víctor Gómez-Mayordomo, María L. Cuadrado, Juan Antonio Valera-Calero |
36 |
[GO] |
2022―Mai―26 |
Long-term evaluation of the COVID-19 pandemic impact on acute stroke management: an analysis of the 21-month data from a medical facility in Tokyo |
Takashi Mitsuhashi, Joji Tokugawa, Hitoshi Mitsuhashi |
37 |
[GO] |
2022―Mai―02 |
Human herpes 6 encephalitis in co-infection with Covid-19 |
A. Di Nora, F. Pizzo, G. Costanza, M. Ruggieri, R. Falsaperla |
38 |
[GO] |
2022―Mai―02 |
Neuromuscular complications after COVID-19 vaccination: a series of eight patients |
Wouter Leemans, Sofie Antonis, Wouter De Vooght, Robin Lemmens, Philip Van Damme |
39 |
[GO] |
2022―Mrz―13 |
Post-acute COVID-19 syndrome presented as a cerebral and systemic vasculitis: a case report |
Jovana Ivanovic, Maja Stojanovic, Aleksandar Ristic, Dragoslav Sokic, Nikola Vojvodic |
40 |
[GO] |
2022―Mrz―03 |
Autonomic dysfunction in patients with COVID-19 |
Yuksel Erdal, Arife Cimen Atalar, Taskın Gunes, Tugba Okluoglu, Nurettin Yavuz, Ufuk Emre |
41 |
[GO] |
2022―Feb―22 |
Acute akinetic-rigid syndrome in COVID-19 encephalitis |
Boby Varkey Maramattom, Asha Kishore |
42 |
[GO] |
2022―Feb―19 |
COVID-19-booster vaccine-induced encephalitis |
Yasmine Sluyts, Yuna Arnst, Toon Vanhemelryck, Harald De Cauwer |
43 |
[GO] |
2022―Feb―17 |
A telephonic survey of health-related quality of life of outpatient department dropout Parkinson’s disease patients during the COVID-19 pandemic |
Atul Goel, Sunil K. Narayan, Ramkumar Sugumaran |
44 |
[GO] |
2022―Jan―31 |
Acute haemorrhagic necrotizing encephalopathy in the setting of SARS-CoV-2 vaccination: a case report and literature review |
Pakeeran Siriratnam, Katherine Buzzard, Gary Yip |
45 |
[GO] |
2022―Jan―30 |
Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19 |
Fereshteh Ghadiri, Abdorreza Naser Moghadasi, Mohammad Ali Sahraian |
46 |
[GO] |
2022―Jan―22 |
Three territory sign in COVID-19 |
Prashant Bhatele, Animesh Das, Awadh Kishor Pandit, Divya M. Radhakrishnan, Achal Kumar Srivastava |
47 |
[GO] |
2022―Jan―21 |
Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study |
Pedro Augusto Sampaio Rocha-Filho, João Eudes Magalhães, Djanino Fernandes Silva, Miriam Carvalho Soares, Lucas Marenga Arruda Buarque, Mylana Dandara Pereira Gama, Felipe Araújo Andrade Oliveira |
48 |
[GO] |
2022―Jan―16 |
Impact of the COVID-19 outbreak on neurological consultation in an emergency department |
Milan Maretta, Matej Škorvánek, Veronika Jurková, Norbert Leško, Zuzana Gdovinová |
49 |
[GO] |
2022―Jan―15 |
Correction to: Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine |
Gulay Ozgen Kenangil, Buse Cagla Ari, Cagan Guler, Mustafa Kemal Demir |
50 |
[GO] |
2022―Jan―10 |
Analysis of neurology consultations in hospitalized patients with COVID-19 |
Merve Hazal Ser, Uygur Tanrıverdi, Çiğdem Özkara, Sabahattin Saip, Ceren Aliş, Zeynep Ece Kaya Güleç, et al. (+9) Gözde Nezir, Esra Koçhan Kızılkılıç, Merve Aktan Süzgün, Hikmet Abbaszade, Şermin Börekçi, Rıdvan Karaali, Osman Kızılkılıç, Ayşegül Gündüz, Feray Karaali Savrun |
51 |
[GO] |
2021―Nov―24 |
Mucormycosis in COVID-19 patients: predisposing factors, prevention and management |
Pavan Kumar Rudrabhatla, Aravind Reghukumar, Sanjeev V. Thomas |
52 |
[GO] |
2021―Nov―12 |
Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report |
Fabio Giuseppe Masuccio, Cristoforo Comi, Claudio Solaro |
53 |
[GO] |
2021―Okt―11 |
Isolated intracranial hypertension following SARS-CoV-2 infection in an adolescent boy: a case report |
Alaa ELmazny, Shireen Mostafa Shousha, Samira Saraya, Rehab Magdy |
54 |
[GO] |
2021―Okt―05 |
Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al. |
Giuliana Galassi, Alessandro Marchioni |
55 |
[GO] |
2021―Okt―01 |
Guillain-Barré syndrome following Covid-19 immunization: a report of two cases |
Francesco Bax, Gian Luigi Gigli, Enrico Belgrado, Laura Brunelli, Mariarosaria Valente |
56 |
[GO] |
2021―Sep―29 |
Teleneurology in a center for neuromuscular diseases during the COVID-19 pandemic |
Kanellos C. Spiliopoulos, Nikolaos Kasdaglis, Dimitra Veltsista, Dimosthenis Lykouras, Maria Lagadinou, Elisabeth Chroni |
57 |
[GO] |
2021―Sep―16 |
Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient |
Dejan Jakimovski, Bianca Weinstock-Guttman |
58 |
[GO] |
2021―Sep―03 |
SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology? |
Antoine Guilmot, Sofia Maldonado Slootjes, Véronique Bissay, Nicolas Dubuisson, Clémence de Broglie, Michel Gille |
59 |
[GO] |
2021―Aug―24 |
From influenza to SARS-CoV-2: etiological evaluation of acute benign childhood myositis |
Emine Tekin, Handan Ayhan Akoğlu |
60 |
[GO] |
2021―Jul―29 |
Is there a common pathophysiological mechanism between COVID-19 and depression? |
Luciano da Silva Lopes, Raquel Oliveira Silva, Guilherme de Sousa Lima, Arthur Caminha de Araújo Costa, Daniela França Barros, Raimundo Pereira Silva-Néto |
61 |
[GO] |
2021―Jul―01 |
Lockdown effects on Parkinson’s disease during COVID-19 pandemic: a pilot study |
Marika Falla, Alessandra Dodich, Costanza Papagno, Alessandro Gober, Pamela Narduzzi, Enrica Pierotti, et al. (+4) Markus Falk, Francesca Zappini, Carlo Colosimo, Luca Turella |
62 |
[GO] |
2021―Jun―19 |
The impact of COVID-19 on acute stroke care in Belgium |
Vincent Raymaekers, Jelle Demeestere, Flavio Bellante, Sofie De Blauwe, Sylvie De Raedt, Anne Dusart, et al. (+11) Lise Jodaitis, Robin Lemmens, Caroline Loos, Ligot Noémie, Matthieu P. Rutgers, Fenne Vandervorst, Geert Vanhooren, Laetitia Yperzeele, Raul G. Nogueira, Thanh N. Nguyen, Peter Vanacker |
63 |
[GO] |
2021―Jun―03 |
A case report of Guillain-Barré syndrome in a pregnant woman infected by COVID-19 |
Masoud Mehrpour, Maliheh Arab, Fahimeh Hadavand, Mahdiyeh Khalafi, Mohammad Khalafi |
64 |
[GO] |
2021―Mai―20 |
Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine |
Gulay Ozgen Kenangil, Buse Cagla Ari, Cagan Guler, Mustafa Kemal Demir |
65 |
[GO] |
2021―Mai―05 |
Neurological diseases and COVID-19: prospective analyses using the UK Biobank |
Nicola Veronese, Lee Smith, Mario Barbagallo, Gianluigi Giannelli, Maria Gabriella Caruso, Anna Maria Cisternino, et al. (+4) Maria Notarnicola, Chao Cao, Thomas Waldhoer, Lin Yang |
66 |
[GO] |
2021―Mai―03 |
Demyelination as a result of an immune response in patients with COVID-19 |
Zahra Shabani |
67 |
[GO] |
2021―Apr―21 |
Investigating the effects of the COVID-19 pandemic on the reasons for application to the emergency department in patients with neurological symptoms |
Cemile Haki, Halil Kaya |
68 |
[GO] |
2021―Apr―05 |
Bilateral peripheral facial palsy following asymptomatic COVID-19 infection: a case report |
Jeroen Kerstens, Lien Deschuytere, Katlijn Schotsmans, Emke Maréchal |
69 |
[GO] |
2021―Apr―02 |
Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay |
Giuliana Galassi, Alessandro Marchioni |
70 |
[GO] |
2021―Apr―01 |
Case series of COVID-19 in patients with myasthenia gravis: a single institution experience |
Sven Županić, Martina Perić Šitum, Maja Majdak, Mirna Karakaš, Silvio Bašić, Davor Sporiš |
71 |
[GO] |
2021―Mrz―02 |
Letter to Editor: Collateral damage: impact of COVID-19 on stroke care in three downtown Los Angeles Community Hospitals |
Diana Escobar, Cara Beth Rogers, Ian Christensen, Michael Jordan, Antonio Liu |
72 |
[GO] |
2021―Feb―09 |
The effects of coronavirus disease 2019 (COVID-19) pandemic on people with epilepsy (PwE): an online survey-based study |
Fathi Abokalawa, Samar Farouk Ahmad, Jasem Al-Hashel, Ahmed Medhat Hassan, Maher Arabi |
73 |
[GO] |
2021―Feb―02 |
Optic neuropathy in a patient with COVID-19 infection |
Patricia Rodrigo-Armenteros, Juan María Uterga-Valiente, Juncal Zabala-Del-Arco, Silvia Taramundi-Argüeso, Lander Antón-Méndez, Juan José Gómez-Muga, Juan Carlos Garcia-Monco |
74 |
[GO] |
2021―Feb―01 |
Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report |
Liming Cao, Lijie Ren |
75 |
[GO] |
2021―Jan―19 |
SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article |
Tasneem Taher, Anum Bilal Sheikh, Farah Anwar, Faisal Khosa |
76 |
[GO] |
2021―Jan―03 |
Deep cerebral venous sinus thrombosis with transient antiphospholipid antibodies in COVID-19 disease |
C. M. J. Loos, L. Yperzeele, C. Jadoul, I. Baar, P. G. Jorens |
77 |
[GO] |
2020―Nov―24 |
Susac syndrome following COVID-19 infection |
Laura Venditti, Antoine Rousseau, Claire Ancelet, Thomas Papo, Christian Denier |
78 |
[GO] |
2020―Nov―23 |
Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy |
J. Finsterer |
79 |
[GO] |
2020―Nov―16 |
Be aware: COVID-19 the new stroke mimicker |
Susanna M. Zuurbier, Hanne-Laure Verschelde, Soetkin Vantyghem, Laetitia Yperzeele, Peter Vanacker |
80 |
[GO] |
2020―Okt―14 |
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19? |
Sebastiaan Dhont, Rutger Callens, Dieter Stevens, Fre Bauters, Jan L. De Bleecker, Eric Derom, Eva Van Braeckel |
81 |
[GO] |
2020―Sep―18 |
Post COVID-19 longitudinally extensive transverse myelitis (LETM)-a case report |
Seyed Mohammad Baghbanian, Farzaneh Namazi |
82 |
[GO] |
2020―Aug―10 |
Letter to the Editor: Neurohospitalist and COVID-19 |
Lisa Duong, Prissilla Xu, Jonathan Eskenazi, Antonio Liu |
83 |
[GO] |
2020―Jul―21 |
Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome |
Giuliana Galassi, Alessandro Marchioni |
84 |
[GO] |
2020―Jul―21 |
Correction to: Neurological manifestations of COVID-19, SARS and MERS |
Kato Verstrepen, Laure Baisier, Harald De Cauwer |
85 |
[GO] |
2020―Jul―07 |
Acute stroke care during the COVID-19 pandemic: difficult, but not impossible! |
Sofia Maldonado Slootjes, Frank Hammer, Jonathan Leempoel, André Peeters |
86 |
[GO] |
2020―Jun―19 |
Neurological manifestations of COVID-19, SARS and MERS |
Verstrepen Kato, Baisier Laure, De Cauwer Harald |
87 |
[GO] |
2020―Jun―10 |
A complication of coronavirus disease 2019: delirium |
Gabriele Cipriani, Sabrina Danti, Angelo Nuti, Cecilia Carlesi, Claudio Lucetti, Mario Di Fiorino |
88 |
[GO] |
2020―Mai―22 |
Are patients with Down syndrome vulnerable to life-threatening COVID-19? |
Harald De Cauwer, Ann Spaepen |